###begin article-title 0
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 59 61 59 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 50 55 <span type="species:ncbi:9606">human</span>
Sp1/3 and NF-1 mediate basal transcription of the human P2X1 gene in megakaryoblastic MEG-01 cells
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 3 5 3 5 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 205 207 205 207 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 387 389 387 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 464 467 464 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 467 469 467 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 499 504 <span type="species:ncbi:9606">human</span>
P2X1 receptors play an important role in platelet function as they can induce shape change, granule centralization and are also involved in thrombus formation. As platelets have no nuclei, the level of P2X1 expression depends on transcriptional regulation in megakaryocytes, the platelet precursor cell. Since nothing is known about the molecular mechanisms regulating megakaryocytic P2X1 expression, this study aimed to identify and functionally characterize the P2X1 core promoter utilized in the human megakaryoblastic cell line MEG-01.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 87 90 87 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 90 92 90 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 126 129 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 129 131 129 131 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1000 1003 1000 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 1003 1005 1003 1005 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1099 1102 1099 1102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 1102 1104 1102 1104 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1115 1120 <span type="species:ncbi:9606">human</span>
###xml 1129 1132 <span type="species:ncbi:10116">rat</span>
###xml 1134 1139 <span type="species:ncbi:10090">mouse</span>
###xml 1144 1147 <span type="species:ncbi:9615">dog</span>
In order to identify cis-acting elements involved in the transcriptional regulation of P2X1 expression, the ability of 4.7 kb P2X1 upstream sequence to drive luciferase reporter gene expression was tested. Low promoter activity was detected in proliferating MEG-01 cells. This activity increased 20-fold after phorbol-12-myristate-13-acetate (PMA) induced differentiation. A transcription start site was detected 365 bp upstream of the start codon by primer extension. Deletion analysis of reporter constructs indicated a core promoter located within the region -68 to +149 bp that contained two Sp1 sites (named Sp1a and Sp1b) and an NF-1 site. Individual mutations of Sp1b or NF-1 binding sites severely reduced promoter activity whereas triple mutation of Sp1a, Sp1b and NF-1 sites completely abolished promoter activity in both untreated and PMA treated cells. Sp1/3 and NF-1 proteins were shown to bind their respective sites by EMSA and interaction of Sp1/3, NF-1 and TFIIB with the endogenous P2X1 core promoter in MEG-01 cells was demonstrated by chromatin immunoprecipitation. Alignment of P2X1 genes from human, chimp, rat, mouse and dog revealed consensus Sp1a, Sp1b and NF-1 binding sites in equivalent positions thereby demonstrating evolutionary conservation of these functionally important sites.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 48 51 48 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 51 53 51 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 390 392 390 392 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
This study has identified and characterized the P2X1 promoter utilized in MEG-01 cells and shown that binding of Sp1/3 and NF-1 to elements in the direct vicinity of the transcription start site is essential for basal transcription. Targeting the function of these transcription factors in megakaryocytes may therefore provide a basis for the future therapeutic manipulation of platelet P2X1 function.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 107 110 107 110 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1&#8211;7</sub>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 268 269 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 344 345 344 345 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 411 412 411 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 494 495 494 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 555 556 555 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 557 558 557 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 601 603 601 603 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 670 671 670 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 763 765 763 765 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 863 865 863 865 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 917 920 917 920 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 1042 1044 1042 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1045 1047 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1105 1107 1105 1107 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1215 1217 1215 1217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1284 1286 1284 1286 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1360 1362 1360 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1405 1407 1405 1407 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1460 1462 1460 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1496 1498 1496 1498 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1306 1321 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1416 1420 <span type="species:ncbi:10090">mice</span>
P2X receptors comprise a family of membrane cation channels gated by extracellular ATP. Seven subtypes (P2X1-7), each encoded for by a separate gene, are present in mammalian species (reviewed by [1]) and these combine to form either homo or hetero trimeric channels [2,3] exhibiting different expression profiles and functional properties. P2X1, the first subtype to be isolated, was cloned over a decade ago [4] and the physiological roles of this channel in the regulation of arterial tone [5] and in the neuronal control of smooth muscle contraction [6,7] are well established. The presence of P2X1 receptors in platelets was discovered shortly after its cloning [8,9], however, it has not been until more recent times that the physiological importance of P2X1 in platelet function has started to fully emerge (for review see [10]). Activation of platelet P2X1 receptors by extracellular ATP results in a rapid Ca2+ influx which activates cytoskeletal events to induce a transient but substantial shape change and granule centralization [11,12], both important early events in platelet activation. P2X1 receptors can also synergize with P2Y, collagen, adrenaline and thrombopoietin receptor mediated responses [10] to enhance platelet function. Furthermore, over expression of P2X1 in the platelets of transgenic mice results in a prothrombotic phenotype [13] whereas an absence of the receptor in P2X1 knockout mice leads to a reduced risk of thrombosis [14] suggesting that the level of P2X1 receptor expression in platelets is of physiological and clinical significance.
###end p 9
###begin p 10
###xml 94 96 94 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 174 176 174 176 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 538 541 538 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 541 543 541 543 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 624 627 624 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 627 629 627 629 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 746 748 746 748 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 821 824 821 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 824 826 824 826 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 877 879 877 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1034 1037 1034 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 1037 1039 1037 1039 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Although the physiological roles and consequences of altered expression levels of platelet P2X1 receptors are becoming increasingly apparent, the mechanisms that regulate P2X1 expression in platelets are poorly understood. Since platelets are cell fragments devoid of any nuclei the complement of channels and receptors present on their surface must ultimately rely on the regulation of gene transcription in the megakaryocyte, the platelet precursor cell. bHLH factors and E proteins are thought to be involved in smooth muscle specific P2X1 transcription [15]. Nothing however is known about transcriptional regulation of P2X1 in megakaryoblastic cells. In order to initiate studies on the transcriptional mechanisms involved in determining P2X1 expression levels in platelets, we have identified and characterized the P2X1 promoter in the megakaryoblastic cell line MEG-01 [16]. We show that Sp1 and NF-1 regulatory elements located in the direct vicinity of the transcriptional start site are essential for basal transcription of P2X1 in MEG-01 cells.
###end p 10
###begin title 11
Results
###end title 11
###begin title 12
###xml 31 33 31 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X<sub>1 </sub></italic>
Cloning and analysis of the P2X1 gene 5' upstream sequence
###end title 12
###begin p 13
###xml 87 90 87 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 90 92 90 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 81 86 <span type="species:ncbi:9606">human</span>
The human genomic BAC clone RP11-167N20 was found to contain all 12 exons of the human P2X1 gene and 64 kb 5' upstream sequence. The 4.772 kb upstream of the ATG start codon was cloned into the pGL-3 Basic luciferase reporter plasmid to generate the plasmid p-4407/+365 and the sequence analyzed by the Proscan computer program [17]. A potential core promoter was predicted at -151 to +99 bp with a promoter score of 70.32.
###end p 13
###begin title 14
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 7 9 7 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
The P2X1 transcription start site is located 365 bp upstream of the start codon
###end title 14
###begin p 15
###xml 27 30 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 30 32 30 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 369 371 369 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 656 658 656 658 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1015 1016 1015 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1158 1160 1158 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1536 1538 1536 1538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1897 1899 1897 1899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1944 1946 1944 1946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 2135 2138 2135 2138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 2138 2140 2138 2140 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 2158 2160 2158 2160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 2232 2237 <span type="species:ncbi:9606">human</span>
To map the location of the P2X1 transcription initiation site in MEG-01 cells, four anti-sense oligonucleotides Pet1, Pet2, Pet3 and Pet4 (Figure 3) were used for primer extension. As positive control we utilized a previously published primer sequence pTXRHR-100 which has been used to map the transcription start site of the thromboxane receptor gene in MEG-01 cells [18]. Similar to previous studies, this control primer yielded a single extension product of ~110 bp (Figure 1A lane 1). A single extension product of ~210 bp was generated by Pet1 (Figure 1A lane 3), two distinct extension products of ~150 bp and ~249 bp, were generated by Pet3 (Figure 1A lane 5), a doublet band of ~66 bp was generated by Pet4 (Figure 1A lane 6) and no extension products were observed from Pet2 (Figure 1A lane 4). Extension products of 66 bp (Pet4), 150 bp (Pet3) and 210 bp (Pet1) correspond to a transcription start site located ~365 bp upstream of the ATG start codon. The Pet2 sequence is very close to this site (Figure 3) and so would not be expected to produce an extension product. An additional extension product of 249 bp produced by the Pet3 primer (Figure 1A, lane 5) indicated the possibility of an additional transcription start site located ~465 bp upstream of start codon. However, no bands corresponding to such a start site were observed with the Pet1, Pet2 or Pet4 primers. Furthermore, subsequent analysis of promoter activity in constructs where this potential site had been removed (p-111/+149 compared to p-68/+149 (Figure 2B)) did not indicate the presence of a functional transcription start site in this region. We therefore attributed the 249 bp band produced by the Pet3 primer as a non-specific extension product. To precisely map the start site, sequencing reactions primed with the same Pet primer used for primer extension were run in parallel to extension reactions (Figure 1B). The 150 bp Pet3 extension product (Figure 1B lane 6) corresponds to a transcription start site located at a "T" residue 365 bp upstream of the ATG start codon. This site is 78 bp downstream of the start site previously described for P2X1 in smooth muscle [15] but matches closely to the EST clone BX644575 which was isolated from human bone marrow, a tissue rich in megakaryocytes.
###end p 15
###begin title 16
###xml 61 64 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 64 66 64 66 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
PMA induced differentiation results in a 20-fold increase in P2X1 reporter gene activity
###end title 16
###begin p 17
###xml 140 142 140 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 176 178 176 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 404 406 404 406 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 435 436 435 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 452 454 452 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 861 863 861 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1236 1238 1236 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1255 1258 1255 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 1258 1260 1258 1260 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 201 206 <span type="species:ncbi:9606">human</span>
In initial studies, we tested the p-4407/+365 construct for promoter activity in three cell lines previously reported to show endogenous P2X1 expression, MEG-01 [9,19], HL-60 [20] and Jurkat [21]. The human kidney proximal tubular epithelial cell line HK2 was used as negative control. Cells were assayed both with and without prior treatment with PMA, a phorbol ester previously reported to increase P2X1 mediated currents in MEG-01 [9,19] and HL-60 [20] cells. Low promoter activity was detected in untreated MEG-01, HL-60 and Jurkat cells but not in HK2 cells (Figure 2A). Treatment of MEG-01 cells with 10 nM PMA caused cells to differentiate to a non-proliferating adherent phenotype and resulted in a ~20 fold increase in promoter activity of p-4407/+365. This PMA-induced increase was also apparent in Jurkat and HL-60 cells but not in HK2 cells (Figure 2A). Comparisons of promoter activity between different constructs in untreated MEG-01 cells proved problematic since promoter activities were not sufficiently above background to allow accurate quantification. PMA-differentiated MEG-01 cells were therefore utilized for subsequent analysis since these cells represent a well characterized model of megakaryocyte maturation [22] and the higher P2X1 promoter activity aided quantification of differences between constructs.
###end p 17
###begin title 18
Deletion analysis of luciferase reporter gene constructs
###end title 18
###begin p 19
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 70 72 70 72 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 828 830 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1154 1156 1152 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 751 756 <span type="species:ncbi:10090">mouse</span>
To define the mechanisms controlling transcriptional regulation of P2X1 in MEG-01 cells, a series of deletion constructs were generated. Gradual deletion of 5' sequence from -4407 to -2235 resulted in no significant change in luciferase activity (Figure 2B) suggesting that no important regulatory elements reside in this ~2 kb region. Removal of sequence between -2235 and -1398 in construct p-1398/+365 however resulted in a 88 +/- 14% increase (p < 0.01) in promoter activity indicating the presence of a repressive element. Sequence analysis of this region revealed a 396 bp polypyrimidine tract located -1801 to -1405 bp which contains 15 copies of the sequence motif 5'-TCCCTCCCTCCC-3'. Interestingly, this same sequence motif is present in the mouse c-Ki-ras promoter where it plays a role in transcriptional regulation [23]. Within this polypyrimidine tract region are clustered multiple potential Sp1, Ets-2 and MAZ transcription factor binding sites. The increase in promoter activity was maintained throughout deletions from 1398 to 190 in the constructs p-805/365, p-454/+365, p-330/+365, and p-190/+365 (p < 0.01 for each construct) (Figure 2B). The difference in promoter activity between constructs p-1398/+365 through to p-190/+365 was not significant. Removal of 3' sequence from +365 to +149 bp (p-190/+149) decreased promoter activity back to the level of the p-4407/+365 construct. Deletion of 5' sequence from -190 to -111 bp (p-111/+149) resulted in a 63 +/- 5% decrease (p < 0.01) in promoter activity. Further deletion of 43 bp 5' sequence in construct p-68/+149 produced no significant change in activity from p-111/+149. Removal of 3' sequence however from +149 to +17 bp in construct p-190/+17 completely abolished promoter activity.
###end p 19
###begin p 20
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 61 63 61 63 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Thus, to summarize the deletion analysis performed on the P2X1 upstream region, promoter activity was stable or increased in 5' deletions from -4407 through to position -190. Deletions past -190 up to position -68 significantly reduced promoter activity whereas removal of 132 bp from +149 to +17 bp abolished promoter function demonstrating that this region contains regulatory elements essential for transcription.
###end p 20
###begin title 21
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 45 47 45 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
In vitro binding of Sp1/3 and NF-1 to the P2X1 promoter
###end title 21
###begin p 22
###xml 148 151 148 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 151 153 151 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 221 223 221 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 508 510 504 506 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 505 510 501 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X<sub>1 </sub></italic>
###xml 887 889 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 991 993 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1049 1051 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1186 1188 1182 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1289 1291 1285 1287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1292 1294 1288 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1346 1349 1342 1345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 1349 1351 1345 1347 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Results from the above deletion analysis suggested that the region -190 to +149 bp plays an important role in the transcriptional regulation of the P2X1 gene (Figure 3). Analysis of this region using the programmes TESS [24] and PROSCAN [17] did not reveal putative TATA or CCAAT boxes, but detected several potential transcription factor binding sites including NF-kappaB, YY-1, GATA-1, NF-1, and multiple Sp1 sites. To begin to understand which specific transcription factors are involved in regulating P2X1 gene transcription we initially performed EMSAs on nuclear extracts from PMA-treated MEG-01 cells using oligonucleotides corresponding to a potential NF-1 site and two Sp1 sites (named Sp1a and Sp1b) located in the immediate vicinity of the transcription start site. The radiolabelled probe O-NF1 containing a potential NF-1 binding site produced a major retarded band (Figure 4A lanes 1 and 3), the formation of which was prevented by an excess of unlabelled O-NF1 itself (Figure 4A lane 4) but not by the mutated O-NF1-mut probe (Figure 4A lane 5). In the presence of an anti-NF-1 antibody, the DNA-protein complexes were either supershifted or remained in the well (Figure 4A lane 2). Similar results for NF-1 supershift complexes have also been reported in previous studies [25,26], we therefore concluded that NF-1 can bind to the P2X1 proximal promoter.
###end p 22
###begin p 23
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 782 784 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 887 889 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 1096 1097 1096 1097 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
The probes O-Sp1a and O-Sp1b corresponding to the Sp1a and Sp1b binding sites respectively, gave rise to three major DNA-protein complexes, the larger two of which appear as a doublet band (Figure 4B lanes 1 and 4). To identify specific transcription factor binding, supershift assays with Sp1 and Sp3 antibodies were performed. The Sp3 antibody produced a supershift ("ss" Figure 4B lanes 3 and 6). Sp1 antibodies caused a decrease in intensity of the doublet band but produced no visible supershifted products (Figure 4B lanes 2 and 5). To further clarify the molecular basis of Sp1/Sp3 interactions with the oligonucleotide probes, competition experiments were performed (Figure 4C). Addition of unlabelled O-Sp1a or O-Sp1b prevented binding of Sp1/Sp3 to labelled probe (Figure 4C lanes 2 and 6). Similarly, addition of an unlabelled commercial consensus Sp1 oligonucleotide (Figure 4C lanes 4 and 8) also prevented Sp1/Sp3 binding to O-Sp1a and O-Sp1b. In contrast O-Sp1a-mut and O-Sp1b-mut did not prevent protein binding (Figure 4C lanes 3 and 7) demonstrating that a 2 bp mutation (Table 1) disrupted Sp1/3 binding.
###end p 23
###begin p 24
###xml 303 305 291 293 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 388 390 376 378 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
An oligonucleotide probe corresponding to the potential NF-kappaB binding site (O-NFkappaB) did not produce super-shifted products after addition of an NF-kappaB antibody (data not shown). In summary EMSAs demonstrated that Sp1, Sp3 and NF-1 transcription factors can bind regulatory elements in the P2X1 proximal promoter implying that these factors are involved in the regulation of P2X1 gene transcription.
###end p 24
###begin title 25
###xml 64 67 64 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 67 69 67 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Sp1 and NF-1 sites are essential for basal transcription of the P2X1 gene
###end title 25
###begin p 26
###xml 111 114 107 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 114 116 110 112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 297 298 293 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 450 452 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 1160 1162 1136 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
We next conducted site-directed mutagenesis to disrupt the Sp1/3, NF-1 and NF-kappaB binding sites in selected P2X1 promoter constructs. Promoter activity of mutated constructs was determined in PMA treated MEG-01 cells and expressed relative to that of the wild type p-190/+149 construct (Figure 5). Single mutation of the NF-kappaB (construct mNF-kappaB) and Sp1a (construct mSp1a) sites produced no significant change in promoter activity (Figure 5A). Single mutation of the NF-1 site (construct mNF-1) or Sp1b site (construct mSp1b) however resulted in 76 +/- 5% (p < 0.01) and 76 +/- 2% (P < 0.01) reductions respectively. A double mutation ablating both NF-1 and NF-kappaB sites simultaneously (construct mut1) reduced promoter activity by 80 +/- 2% (p < 0.01), whereas double mutation of Sp1a and Sp1b sites (construct mut2) reduced activity by 92% +/- 1 (p < 0.01). Simultaneous mutation of NF-1 and Sp1b sites (construct mut3), the NF-1 site together with Sp1a and Sp1b sites (construct mut4), or deletion of the fragment from +18 to +149 bp which removes both Sp1a and Sp1b sites (construct p-190/+17) effectively abolished promoter activity (Figure 5A).
###end p 26
###begin p 27
###xml 216 218 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 475 477 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
In order to confirm the apparent redundancy of the potential NF-kappaB site, we generated a further set of mutations in the plasmid p-111/+149, a construct where the potential NF-kappaB site has been removed (Figure 5B). Whilst removal of 79 bp from -190 to -111 resulted in a ~50% decrease in promoter activity, the overall pattern of promoter activity resulting from Sp1 and NF-1 binding site mutations was very similar to that observed in the p-190/+149 mutations (Figure 5A).
###end p 27
###begin p 28
###xml 2 5 2 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 5 7 5 7 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 682 684 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 111 116 <span type="species:ncbi:9606">human</span>
A P2X1 transcription start site 78 bp upstream from site identified in this current study has been reported in human smooth muscle cells [15]. If this same site is utilized in MEG-01 cells then its removal in deletion constructs would be expected to abolish promoter activity. To test this hypothesis and to further delineate a functional core promoter, the construct p-68/+149 was generated. p-68/+149 displayed a promoter activity 32 +/- 3% that of the p-190/+149 construct. Single and double site-directed mutations of Sp1 and NF-1 binding sites in this p-68/+149 construct again showed a similar pattern of promoter activity to that observed in the p-190/+149 construct (Figure 5C).
###end p 28
###begin p 29
###xml 106 109 106 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 109 111 109 111 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 585 588 585 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 588 590 588 590 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
From the above mutation and previous deletion analysis, we defined the region spanning -68 to +149 as the P2X1 core promoter composing of a single NF-1 binding site and two Sp1-binding sites. To prove the importance of these sites in controlling basal transcription, the Sp1a, Sp1b and NF-1 sites were mutated in the original 4.7 kb reporter construct p-4407/+365 to generate the construct p-4407/+365(mut4). Promoter activity from this triple mutated construct was abolished in both untreated and PMA-treated MEG-01 cells (Figure 5D) confirming the essential roles of Sp1 and NF-1 in P2X1 basal transcription.
###end p 29
###begin title 30
###xml 51 54 51 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 54 56 54 56 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Direct binding of Sp1/3 and NF-1 to the endogenous P2X1 core promoter
###end title 30
###begin p 31
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 59 61 59 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 211 214 211 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 214 216 214 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 230 238 230 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 266 272 266 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hsp70 </italic>
###xml 276 287 276 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">histone H4 </italic>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 502 508 502 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 727 730 727 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 730 732 730 732 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 757 765 757 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
Having identified Sp1, Sp3 and NF-1 sites essential for P2X1 reporter gene function, we next utilized ChIP to determine whether the corresponding transcription factors are physically recruited to the endogenous P2X1 core promoter in vivo (Figure 6). Primers for the Hsp70 and histone H4 promoters were used as positive controls as Sp1 and Sp3 have previously been detected at these promoters by ChIP assay [27,28]. As a negative control, parallel experiments using primers for the coding region of the GAPDH gene were performed. Antibodies for Sp1, Sp3, NF-1 and TFIIB in ChIP assays using chromatin isolated from PMA-treated MEG-01 cells resulted in enrichment of the DNA genomic segment harboring the region -197/+166 of the P2X1 gene thus confirming the in vivo recruitment of these factors to the core promoter.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 17 19 17 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 151 153 151 153 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 353 356 353 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 356 358 356 358 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 415 418 415 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 418 420 418 420 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Regulation of P2X1 transcription in megakaryocytic cells is of physiological and clinical importance as ultimately this will influence the level of P2X1 receptor present on platelets, excessive activation of which can lead to thrombosis, cardiovascular disease and stroke. As a first step towards understanding the transcriptional mechanisms regulating P2X1 expression in megakaryocytic cells, we have analyzed the P2X1 promoter in MEG-01 cells. We identified a transcription start site 365 bp upstream of the start codon and defined a core promoter located within the region -68 to +149 bp. Two Sp1 sites and an NF-1 site in the core promoter were shown to be critical for basal transcription.
###end p 33
###begin p 34
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 7 9 7 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 549 551 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 875 877 875 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1047 1049 1047 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1050 1052 1050 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1094 1097 1094 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 1097 1099 1097 1099 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
The P2X1 core promoter was found not to possess "TATA" or "CCAAT" elements but contained Sp1 and NF-1 sites critical for basal transcription. Mammalian promoters lacking a TATA box often contain Sp1 elements and rely on Sp1 to recruit TATA-binding protein and guide RNA polymerase II to the initiator site [29-31]. Sp1 and Sp3 are members of a large family of transcription factors that regulate transcription through interactions with GC-boxes. They are both zinc finger proteins that bind the same DNA recognition sequences with similar affinity [32]. Despite ubiquitous expression, tissue-specific gene activation by Sp1 and Sp3 may be achieved by a variety of mechanisms including variability in the concentration of Sp1 and Sp3 [32], interactions of Sp1 with tissue specific transcription factors [33] and tissue specific post-translational modification of Sp1 and Sp3 [32]. Sp1/3 can regulate gene transcription through a variety of mechanisms, functioning as either a basal promoter element or an upstream activator, depending on promoter [34,35]. Two Sp1/3 sites were identified in the P2X1 promoter and mutation of the Sp1b (+71 to +79) site most markedly reduced promoter activity. Single mutation of the Sp1a (+44 to +52) site did not significantly reduce transcription. However, simultaneous mutation of both Sp1a and Sp1b together entirely abolished transcriptional activity. Thus, the Sp1b site can completely compensate for the loss of the Sp1a site but Sp1a can only partially compensate for the loss of Sp1b suggesting that whilst both sites may be utilized in basal transcription, the Sp1b site plays a more prominent role.
###end p 34
###begin p 35
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 23 25 23 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 355 358 355 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 358 360 358 360 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 437 438 437 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 626 629 626 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 629 631 629 631 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
An NF-1 site in the P2X1 core promoter was also found to be important for transcription. NF-1 proteins are recruited to promoters in a cell type specific manner and can associate with different regulators to either activate or repress transcription depending on the promoter and cellular context [36,37]. Site-directed mutagenesis of the NF-1 site in the P2X1 core promoter significantly reduced transcriptional activity by ~80% (Figure 5). Simultaneous mutation of both NF-1 and Sp1b sites completely abolished promoter activity suggesting that NF-1 and Sp1/3 may act synergistically to recruit the initiation complex to the P2X1 core promoter.
###end p 35
###begin p 36
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 13 15 13 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 232 234 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 277 279 277 279 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 397 400 397 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 400 402 400 402 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 552 554 552 554 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 609 611 609 611 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 696 699 696 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 699 701 699 701 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1030 1032 1030 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1108 1110 1108 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1111 1113 1111 1113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1181 1183 1181 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1184 1186 1184 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1243 1246 1243 1246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 1246 1248 1246 1248 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human P2X1 promoter identified in this study shows characteristics typical of those normally associated with housekeeping genes: lack of classical TATA or CCAAT boxes, an increased GC content and critical Sp1 and NF-1 elements [38]. This would appear ideally suited for P2X1 expression in megakaryocytes since constant synthesis is required for platelet production. Constitutive expression of P2X1 however does not occur in all hematic cell types and their progenitors as neutrophils, monocytes and lymphocytes show no significant expression of P2X1 [39,40]. This suggests that tight repression of the P2X1 promoter occurs and that release from this repression may be an important feature of P2X1 transcriptional regulation. Deletion analysis performed in this study identified a repressive element in an upstream region containing a 396 bp polypyrimidine tract located -1801 to -1405. Removal of this tract in deletion constructs p-1398/+365 through to p-190/+365 resulted in a ~90-100% increase in promoter activity (Figure 2B). Polypyrimidine tracts can harbor multiple binding sites for Sp1 and Sp3 [41,42] and play important roles in the regulation of gene transcription [43,44]. A possible mechanism for the repressive effect of the P2X1 polypyrimidine tract could be that this region facilitates a local sequestration of Sp1/3 factors hindering their binding to the Sp1a and Sp1b sites further downstream in the core promoter.
###end p 36
###begin p 37
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 242 245 242 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 245 247 245 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 333 336 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 336 338 336 338 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 606 607 606 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7</xref>
###xml 688 690 688 690 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 768 771 768 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 771 773 771 773 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 182 187 <span type="species:ncbi:9606">human</span>
###xml 349 354 <span type="species:ncbi:10090">mouse</span>
###xml 363 366 <span type="species:ncbi:9615">dog</span>
###xml 371 374 <span type="species:ncbi:10116">rat</span>
###xml 387 392 <span type="species:ncbi:9606">human</span>
Important transcriptional regulatory elements often show conservation between species [45]. We therefore investigated whether the NF-1, Sp1a and Sp1b binding sites identified in the human promoter are also present in the upstream sequence of P2X1 genes from other species. Using BLAST searches of genomic sequence data we identified P2X1 genes from mouse, chimp, dog and rat. Similar to human, the upstream regions of these genes were also GC-rich and contained no "TATA" or "CCAAT" elements. Sequence alignment revealed NF-1, Sp1a and Sp1b sites in identical positions across all species examined (Figure 7). These results demonstrate a conserved core promoter structure in mammalian P2X1 genes and suggest that the involvement of Sp1/3 and NF-1 in the regulation of P2X1 transcription has been conserved during evolution.
###end p 37
###begin p 38
###xml 206 209 202 205 <sub xmlns:xlink="http://www.w3.org/1999/xlink">IIb</sub>
###xml 213 215 206 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 216 218 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 219 221 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 367 369 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 391 393 384 386 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 423 425 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 434 436 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 450 452 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 554 556 547 549 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 575 577 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 609 612 602 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 612 614 605 607 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 834 836 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 837 839 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 931 933 924 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 934 936 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 983 985 976 978 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1049 1052 1042 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 1052 1054 1045 1047 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1143 1145 1136 1138 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1208 1211 1201 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 1211 1213 1204 1206 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
PMA-induced differentiation of MEG-01 cells is widely used as a model of megakaryocytic maturation and is known to increase the expression of megakaryocytic lineage specific antigens, such as integrin alphaIIbbeta3 [22,46]. PMA activates signaling cascades via activation of PKC and other C1 domain containing receptors resulting in a wide range of cellular effects [47]. PMA can enhance P2X1 mediated responses in MEG-01 [19], THP1 [39], and HL-60 [20] cells and is also thought to have more acute effects by increasing phosphorylation of a putative P2X1 accessory protein [48]. In this study, we found that P2X1 promoter activity increased ~20-fold in PMA-differentiated MEG-01 cells compared to untreated cells. Several studies have shown Sp1 DNA-binding activity and expression level to increase upon treatment of cells with PMA [49-53]. Similarly, PMA induction has been shown to increase the formation of NF-1 DNA complexes [54,55]. We therefore speculate that PMA enhances P2X1 ion channel function through the actions of Sp1 and NF-1 at the P2X1 core promoter resulting in an increase in gene transcription and the synthesis of new P2X1 protein. The signaling pathways that link PMA stimulation with P2X1 gene activation and whether these result in alterations in the levels of Sp1 and NF-1 or in protein modifications such as phosphorylation altering the affinity of factors for their respective binding sites remain to be determined.
###end p 38
###begin title 39
Conclusion
###end title 39
###begin p 40
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 26 27 26 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X<sub>1</sub></italic>
###xml 460 461 460 461 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 457 461 457 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X<sub>1</sub></italic>
###xml 585 586 585 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 582 586 582 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X<sub>1</sub></italic>
###xml 869 871 869 871 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
The in vivo control of P2X1 transcription in megakaryocytes is undoubtedly a complex combinatorial process involving the integration of a large number of protein-protein and protein-DNA interactions that mediate cell type specific expression during megakaryocyte differentiation and the ability respond to regulatory inputs. This study provides the first steps towards unraveling the complexities of this control by providing the fundamental information of P2X1 core promoter location and composition in a megakaryocytic cell line. We demonstrate that Sp1 and NF-1 are critical for P2X1 core promoter function in both proliferating and PMA-differentiated MEG-01 cells. The targeting of signaling pathways that influence the function of these transcription factors in megakaryocytes may therefore provide the basis for the future therapeutic manipulation of platelet P2X1 function.
###end p 40
###begin title 41
Methods
###end title 41
###begin title 42
Reporter constructs
###end title 42
###begin p 43
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 66 68 66 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 177 181 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Pfu </italic>
###xml 4 9 <span type="species:ncbi:9606">human</span>
###xml 57 62 <span type="species:ncbi:9606">human</span>
The human genomic BAC clone (RP11-167N20) containing the human P2X1 gene was obtained from the Sanger Institute. 4.772 kb upstream of the start codon was amplified by PCR using Pfu polymerase (Promega, Madison, WI) and cloned into pGL3-Basic (Promega). A series of 5' deletion constructs were created either by restriction enzyme digestion with Mlu I/Hind III or via a PCR based approach to introduce Mlu I/Hind III sites via primers.
###end p 43
###begin title 44
Cell culture
###end title 44
###begin p 45
###xml 155 157 149 151 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 222 228 <span type="species:ncbi:9913">bovine</span>
###xml 342 348 <span type="species:ncbi:9913">bovine</span>
MEG-01, HL-60 and Jurkat cells were purchased from the German National Resource Centre for Biological Material (DSMZ) and maintained at 37degreesC in 5% CO2 in RPMI 1640 medium supplemented with 10% heat-inactivated fetal bovine serum. HK2 cells were maintained in Dulbecco's modified Eagle's medium-Ham's F12 mix supplemented with 10% fetal bovine serum and 2 mM L-glutamine.
###end p 45
###begin title 46
Site-directed mutagenesis
###end title 46
###begin p 47
###xml 176 179 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 179 181 179 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Point mutations were introduced into potential Sp1 and/or NF-1 binding sites by a two step cloning strategy. A 339 bp fragment (spanning from -190 to +149 bp) was cut from the P2X1 pGL3-Basic plasmid, cloned into the Mlu I/Hind III sites of pCR-Scripttrade mark and used as template for mutagenesis using the QuikChangetrade mark system (Stratagene, La, Jolla CA). Mutated fragments were then re-cloned into the Mlu I/Hind III sites of the corresponding pGL3-Basic vectors. Double (mut1, mut2 and mut3) and triple-site (mut4) mutation constructs were generated by consecutive rounds of mutagenesis. The triple mutation construct p-4407(mut4) was generated by replacing a Sal I/Hind III fragment with the equivalent mutated Sal I/Hind III fragment from the plasmid mut4.
###end p 47
###begin title 48
###xml 12 15 12 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 15 17 15 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Mapping the P2X1 transcription start site
###end title 48
###begin p 49
###xml 190 192 168 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
###xml 222 223 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 446 447 424 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
Poly(A) RNA was isolated from PMA (10 nM) treated MEG-01 cells using RNAWIZtrade mark total RNA and Poly(A) Puristtrade mark mRNA purification kits (Ambion, Austin, TX). Extension of [gamma-32P]ATP labeled primers (Figure 1) was performed using the Promega Primer Extension System (Promega, E3030). Size of extension products was determined by resolution on denaturing 8% polyacrylamide gels. Locations of the primers used are depicted in Figure 3.
###end p 49
###begin title 50
Transient transfection and luciferase assays
###end title 50
###begin p 51
###xml 34 36 34 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 100 103 100 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 103 105 103 105 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 136 140 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 256 260 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
For transient transfections 5 x 104 cells were plated in 96-well plates and incubated with 80 ng of P2X1 reporter plasmid, 20 ng of pRL-SV40 and 0.3 mul of transfection reagent (GeneJuicetrade mark, Novagen Madison, WI). The Renilla luciferase plasmid pRL-SV40 (Promega) was used as internal control for transfection efficiency. Following transfection, cells were cultured in the absence or presence of 10 nM PMA. The Dual-Glotrade mark Luciferase Assay (Promega) was used to determine firefly and renilla luciferase activity 48 hours after transfection in 96-well plates. Firefly luciferase activity was normalized to Renilla activity in each transfection. All plasmids were purified using Qiagen columns (Qiagen, Valencia CA) and at least two preparations per plasmid were tested. Transfections were done in triplicate in each experiment and at least 3 experiments were performed for each construct. Data are presented as means of experiments +/- Standard error. Differences between means of control and experimental constructs were assessed by Dunnett's test. Differences between experimental constructs within a dataset were assessed using Tukey's multiple comparison test.
###end p 51
###begin title 52
Electrophoretic mobility shift assays
###end title 52
###begin p 53
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 567 568 566 567 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1182 1183 1180 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
Nuclear proteins were isolated from PMA-treated (10 nM, 48 hours) MEG-01 cells essentially as described by Hurst [56]. EMSAs were performed using the Promega EMSA kit on at least three different preparations of nuclear extract for each experiment. Bands that could not be competed by cold unlabelled oligonucleotide, consensus oligonucleotide or the non-specific competitor Poly dI-dC were classed as non-specific binding complexes. Nuclear protein (5.0 mug) was incubated with or without a 100-fold molar excess of unlabelled competitor DNA in 4% glycerol, 1 mM MgCl2, 0.5 mM dithiothreitol, 0.5 mM EDTA, 50 mM NaCl, 10 mM Tris-HCl, pH 7.5 and 2.0 mug poly (dI-dC) on ice for 15 minutes, followed by addition of the radiolabelled probe. For supershift assays, antibodies (Santa Cruz Biotechnology Inc, Santa Cruz, CA) were added to the reaction mixture 25 minutes prior to the probe. DNA-protein complexes were resolved by electrophoresis on 6% polyacrylamide gels. Commercial double-stranded oligonucleotides used were as follows: Sp1, 5'-ATTCGATCGGGGCGGGGCGAGC-3', (Promega); NF-1, 5'-TTTTGGATTGAAGCCAATATGATAA-3' (Santa Cruz). Other oligonucleotide sequences are shown in Table 1.
###end p 53
###begin title 54
Chromatin Immunoprecipitation
###end title 54
###begin p 55
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 159 161 159 161 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 736 739 735 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 739 740 738 739 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 742 744 741 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H4</italic>
###xml 750 756 749 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hsp70 </italic>
###xml 803 809 802 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
Formaldehyde cross-linking and chromatin immunoprecipitation were performed as described by Okada and co-workers [57]. After PMA treatment for 48 hours, 2 x 106 cells were treated with formaldehyde for 10 minutes followed by the addition of 0.125 M glycine. Cells were washed twice in PBS and re-suspended in lysis buffer (1% SDS, 10 mM EDTA, 50 mM HEPES, 10 mul/ml Protease inhibitor Cocktail (Sigma) adjusted to pH 7.9 with KOH). After sonication to an average fragment size of 500 bp, protein-DNA cross-linked products were enriched by immunoprecipitation. Samples without antibody were included as negative controls. After reversal of cross links and DNA purification, the extent of enrichment was monitored by PCR using primers to P2X1, H4, and Hsp70 promoter fragments and to the coding region of GAPDH as negative control. The input sample was processed with the rest of the samples from the point at which the cross links were reversed.
###end p 55
###begin title 56
Abbreviations
###end title 56
###begin p 57
EMSA, electrophoretic mobility shift assay; PMA, phorbol-12-myristate-13-acetate; S.E, standard error; ChIP, chromatin immunoprecipitation.
###end p 57
###begin title 58
Authors' contributions
###end title 58
###begin p 59
###xml 88 89 88 89 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 85 89 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X<sub>1</sub></italic>
JZ carried out the experimentation and planned the study. SJE cloned the full length P2X1 reporter construct, planned the study and wrote the manuscript.
###end p 59
###begin p 60
Both authors read and approved the final manuscript
###end p 60
###begin title 61
Acknowledgements
###end title 61
###begin p 62
###xml 67 72 <span type="species:ncbi:28478">Tania</span>
We thank Dr Gary Willars for advice on statistical analysis and Dr Tania Webb for critical review of the manuscript. This work was funded by Biotechnology and Biological Sciences Research Council UK
###end p 62
###begin article-title 63
Molecular physiology of P2X receptors
###end article-title 63
###begin article-title 64
Atomic force microscopy imaging demonstrates that P2X2 receptors are trimers but that P2X6 receptor subunits do not oligomerize
###end article-title 64
###begin article-title 65
P2X1 and P2X3 receptors form stable trimers: a novel structural motif of ligand-gated ion channels
###end article-title 65
###begin article-title 66
A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP
###end article-title 66
###begin article-title 67
###xml 26 30 <span type="species:ncbi:10090">mice</span>
P2X(1) receptor-deficient mice establish the native P2X receptor and a P2Y6-like receptor in arteries
###end article-title 67
###begin article-title 68
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Reduced vas deferens contraction and male infertility in mice lacking P2X1 receptors
###end article-title 68
###begin article-title 69
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
###xml 134 139 <span type="species:ncbi:10090">mouse</span>
P2X receptor expression in mouse urinary bladder and the requirement of P2X(1) receptors for functional P2X receptor responses in the mouse urinary bladder smooth muscle
###end article-title 69
###begin article-title 70
###xml 82 87 <span type="species:ncbi:9606">human</span>
Activation of receptor-operated cation channels via P2X1 not P2T purinoceptors in human platelets
###end article-title 70
###begin article-title 71
###xml 34 39 <span type="species:ncbi:9606">human</span>
Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell lines
###end article-title 71
###begin article-title 72
Emerging roles for P2X1 receptors in platelet activation
###end article-title 72
###begin article-title 73
Potentiation of platelet activation through the stimulation of P2X1 receptors
###end article-title 73
###begin article-title 74
Platelet shape change evoked by selective activation of P2X1 purinoceptors with alpha,beta-methylene ATP
###end article-title 74
###begin article-title 75
###xml 51 66 <span type="species:ncbi:10090">transgenic mice</span>
Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype
###end article-title 75
###begin article-title 76
A role of the fast ATP-gated P2X1 cation channel in thrombosis of small arteries in vivo
###end article-title 76
###begin article-title 77
###xml 14 19 <span type="species:ncbi:9606">human</span>
Regulation of human P2X1 promoter activity by beta helix-loop-helix factors in smooth muscle cells
###end article-title 77
###begin article-title 78
###xml 25 30 <span type="species:ncbi:9606">human</span>
Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome
###end article-title 78
###begin article-title 79
Predicting Pol II promoter sequences using transcription factor binding sites
###end article-title 79
###begin article-title 80
###xml 21 26 <span type="species:ncbi:9606">human</span>
The 5' region of the human thromboxane A(2) receptor gene
###end article-title 80
###begin article-title 81
Thrombopoietin enhances rapid current responses mediated by P2X1 receptors on megakaryocytic cells in culture
###end article-title 81
###begin article-title 82
P2X1 receptor activation in HL60 cells
###end article-title 82
###begin article-title 83
###xml 35 40 <span type="species:ncbi:9606">human</span>
Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-kappa B
###end article-title 83
###begin article-title 84
Phorbol esters: useful tools to study megakaryocyte differentiation
###end article-title 84
###begin article-title 85
An S1 nuclease-sensitive homopurine/homopyrimidine domain in the c-Ki-ras promoter interacts with a nuclear factor
###end article-title 85
###begin article-title 86
Using TESS to Predict Transcription Factor Binding Sites in DNA Sequence
###end article-title 86
###begin article-title 87
###xml 44 47 <span type="species:ncbi:10116">rat</span>
Gene structure and promoter analysis of the rat BTEB2 gene
###end article-title 87
###begin article-title 88
###xml 59 64 <span type="species:ncbi:9606">human</span>
###xml 127 132 <span type="species:ncbi:9606">human</span>
NF-1C, Sp1, and Sp3 are essential for transcription of the human gene for P450c17 (steroid 17alpha-hydroxylase/17,20 lyase) in human adrenal NCI-H295A cells
###end article-title 88
###begin article-title 89
###xml 76 81 <span type="species:ncbi:9606">human</span>
Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene
###end article-title 89
###begin article-title 90
###xml 15 20 <span type="species:ncbi:9606">human</span>
Association of human TFIID-promoter complexes with silenced mitotic chromatin in vivo
###end article-title 90
###begin article-title 91
Sp1 activation of a TATA-less promoter requires a species-specific interaction involving transcription factor IID
###end article-title 91
###begin article-title 92
###xml 82 86 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
The promoter-specific transcription factor Sp1 binds to upstream sequences in the SV40 early promoter
###end article-title 92
###begin article-title 93
Transcription from a TATA-less promoter requires a multisubunit TFIID complex
###end article-title 93
###begin article-title 94
Gene regulation by Sp1 and Sp3
###end article-title 94
###begin article-title 95
###xml 57 62 <span type="species:ncbi:9606">human</span>
Estrogen-induced c-fos protooncogene expression in MCF-7 human breast cancer cells: role of estrogen receptor Sp1 complex formation
###end article-title 95
###begin article-title 96
Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins
###end article-title 96
###begin article-title 97
Transcription factor Sp3 antagonizes activation of the ornithine decarboxylase promoter by Sp1
###end article-title 97
###begin article-title 98
Roles of the NFI/CTF gene family in transcription and development
###end article-title 98
###begin article-title 99
The Nuclear Factor I (NFI) gene family in mammary gland development and function
###end article-title 99
###begin article-title 100
###xml 36 41 <span type="species:ncbi:9606">human</span>
Basal transcriptional regulation of human damage-specific DNA-binding protein genes DDB1 and DDB2 by Sp1, E2F, N-myc and NF1 elements
###end article-title 100
###begin article-title 101
###xml 83 88 <span type="species:ncbi:9606">human</span>
###xml 110 115 <span type="species:ncbi:9606">human</span>
The P2X1 receptor, an adenosine triphosphate-gated cation channel, is expressed in human platelets but not in human blood leukocytes
###end article-title 101
###begin article-title 102
###xml 40 45 <span type="species:ncbi:9606">human</span>
P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells
###end article-title 102
###begin article-title 103
A polypyrimidine/polypurine tract within the Hmga2 minimal promoter: a common feature of many growth-related genes
###end article-title 103
###begin article-title 104
###xml 54 59 <span type="species:ncbi:9606">human</span>
Characterization of the basal promoter element of the human type 5 17beta-hydroxysteroid dehydrogenase gene
###end article-title 104
###begin article-title 105
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human amiloride-sensitive epithelial Na+ channel gamma subunit promoter: functional analysis and identification of a polypurine-polypyrimidine tract with the potential for triplex DNA formation
###end article-title 105
###begin article-title 106
###xml 44 49 <span type="species:ncbi:9606">human</span>
Triple helix formation with the promoter of human alpha1(I) procollagen gene by an antiparallel triplex-forming oligodeoxyribonucleotide
###end article-title 106
###begin article-title 107
Eukaryotic regulatory element conservation analysis and identification using comparative genomics
###end article-title 107
###begin article-title 108
Biogenesis of endoplasmic reticulum proteins involved in Ca2+ signalling during megakaryocytic differentiation: an in vitro study
###end article-title 108
###begin article-title 109
###xml 13 18 <span type="species:ncbi:9606">human</span>
Defining the human targets of phorbol ester and diacylglycerol
###end article-title 109
###begin article-title 110
G-protein-coupled receptor regulation of P2X1 receptors does not involve direct channel phosphorylation
###end article-title 110
###begin article-title 111
###xml 97 102 <span type="species:ncbi:9606">human</span>
Cell-type specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitro
###end article-title 111
###begin article-title 112
Transcriptional regulation of lysosomal acid lipase in differentiating monocytes is mediated by transcription factors Sp1 and AP-2
###end article-title 112
###begin article-title 113
Transcription factors Sp1 and AP-2 mediate induction of acid sphingomyelinase during monocytic differentiation
###end article-title 113
###begin article-title 114
###xml 44 49 <span type="species:ncbi:9606">Human</span>
PMA Induces the MUC5AC Respiratory Mucin in Human Bronchial Epithelial Cells, via PKC, EGF/TGF-alpha, Ras/Raf, MEK, ERK and Sp1-dependent Mechanisms
###end article-title 114
###begin article-title 115
###xml 45 50 <span type="species:ncbi:9606">human</span>
Sp1 and Sp3 are involved in up-regulation of human deoxyribonuclease II transcription during differentiation of HL-60 cells
###end article-title 115
###begin article-title 116
###xml 0 8 <span type="species:ncbi:10632">JC virus</span>
###xml 27 32 <span type="species:ncbi:9606">human</span>
JC virus multiplication in human hematopoietic progenitor cells requires the NF-1 class D transcription factor
###end article-title 116
###begin article-title 117
###xml 99 102 <span type="species:ncbi:10116">rat</span>
Intracellular signaling factors--enhanced hepatic nuclear protein binding to TTGGC sequence in the rat regucalcin gene promoter: involvement of protein phosphorylation
###end article-title 117
###begin article-title 118
The cellular transcription factor CREB corresponds to activating transcription factor 47 (ATF-47) and forms complexes with a group of polypeptides related to ATF-43
###end article-title 118
###begin article-title 119
Upstream stimulatory factors stimulate transcription through E-box motifs in the PF4 gene in megakaryocytes
###end article-title 119
###begin title 120
Figures and Tables
###end title 120
###begin p 121
###xml 4 7 4 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 7 9 7 9 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 0 79 0 79 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The <italic>P2X</italic><sub>1 </sub>transcription start site is located 365 bp upstream of the start codon</bold>
###xml 84 86 84 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink">32</sup>
The P2X1 transcription start site is located 365 bp upstream of the start codon. A) 32P-labelled primers Pet1, Pet2, Pet3 and Pet4 and Con (control primer pTXRHR-100) were annealed to poly(A) RNA from PMA-treated MEG-01 cells and extended with reverse transcriptase. Extension products for Pet1, Pet3 and Pet4 that equate to the same transcription start site are indicated with arrows. (M), molecular mass marker. B) Pet3 extension reaction (lane 6) run in parallel with a sequencing ladder. The location of primers is depicted in Figure 3.
###end p 121
###begin p 122
###xml 12 15 12 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 15 17 15 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 0 69 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Activity of <italic>P2X</italic><sub>1 </sub>promoter constructs in transient transfection assays</bold>
###xml 314 317 314 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 317 319 317 319 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Activity of P2X1 promoter constructs in transient transfection assays. A) Promoter activity of p-4407/+365 was determined both with (+) and without (-) the prior treatment of cells with 10 nM PMA. Data are means of absolute firefly luciferase activity of three independent transfections. B) Luciferase activity of P2X1 deletion constructs in PMA treated MEG-01 cells. TSS, transcription start site. PT depicts a polypyrimidine tract located from -1801 to -1405 bp. Values are presented as means of at least three experiments and normalized against the construct p-4407/+365. Names of plasmid constructs correspond to the 5' and 3' ends of the insert relative to the transcription start site e.g. construct p-4407/+365 extends from 4407 bp 5' to 365 bp 3' of the transcription start site.
###end p 122
###begin p 123
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 19 21 19 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Sequence of the <italic>P2X</italic><sub>1 </sub>proximal promoter region</bold>
Sequence of the P2X1 proximal promoter region. Potential transcription factor binding sites are underlined and in bold. Oligonucleotide sequences used for primer extension analysis (Pet1-4) are indicated by horizontal arrows. End points of plasmid deletion constructs in this region are indicated by "p" and number above the sequence. Sequence numbering is relative to the transcription start site indicated as +1. The translation initiation ATG is boxed. The EMBL/Genbank accession number of this sequence is .
###end p 123
###begin p 124
###xml 0 45 0 45 <bold xmlns:xlink="http://www.w3.org/1999/xlink">EMSA assays on NF-1 and Sp1/Sp3 binding sites</bold>
EMSA assays on NF-1 and Sp1/Sp3 binding sites. A) Competition experiments were performed in the presence of excess unlabelled O-NF1 (lane 4) and unlabelled mutated O-NF1-mut (lane 5). Complexes supershifted by pre-incubation with an NF-1 antibody (NF-1Ab, lane 2) are marked "SS". "NS" indicates non specific binding complexes, the level of which varied between individual nuclear extractions (lanes 1 and 3). "F" indicates free probe. B) Supershift assays using Sp1 (lanes 2 and 5) and Sp3 (lanes 3 and 6) specific antibodies. C) Competition experiments in the absence (lanes 1 and 5) or presence of excess of unlabelled competitors: Lanes 2 and 6, an excess of unlabelled O-Sp1a or O-Sp1b probe respectively. Lanes 3 and 7, an excess of unlabelled mutated oligonucleotide O-Sp1a-mut and O-Sp1b-mut respectively. Lanes 4 and 8, an excess of a consensus Sp1 oligonucleotide (Promega, E323A).
###end p 124
###begin p 125
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mutation analysis of transcription factor binding sites</bold>
###xml 187 190 183 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 190 192 186 188 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Mutation analysis of transcription factor binding sites. A series of luciferase reporter constructs harbouring site-directed mutations in the NF-kappaB, NF-1 and Sp1 binding sites of the P2X1 proximal promoter region were assayed for promoter activity in PMA-treated MEG-01 cells (sequences of mutations are shown in Table 2). Shaded symbols represent mutated binding sites. Values are presented as means +/- S.E of at least three independent experiments and are normalized against the wild type p-190/+149 construct for panels A to C and the wild type construct p-4407/+365 in panel D. A) Effects of mutations in the construct p-190/+149. B) Effect of mutation after removal of the potential NF-kappaB binding site. C) Effect of mutation after removal of the transcription start site that is utilized by smooth muscle cells [15]. Dotted vertical arrow (TSS) represents the transcription start site determined in this study. D) The Sp1a, Sp1b and NF-1 sites were mutated in the original full length 4.7 kb reporter construct p-4407/+365 to generate the triple mutated construct p-4407/+365(mut4). Promoter activities were determined in MEG-01 cells either treated (+) or untreated (-) with PMA.
###end p 125
###begin p 126
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 45 47 45 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Transcription factors bind the endogenous <italic>P2X</italic><sub>1 </sub>promoter</bold>
###xml 325 328 325 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 328 329 328 329 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 331 334 331 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H4 </italic>
###xml 338 344 338 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hsp70 </italic>
###xml 365 371 365 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
###xml 654 657 654 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 657 658 657 658 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 660 663 660 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H4 </italic>
###xml 667 673 667 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hsp70 </italic>
###xml 697 703 697 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAPDH </italic>
Transcription factors bind the endogenous P2X1 promoter. Formaldehyde cross-linked chromatin was prepared from PMA-treated MEG-01 cells and immunoprecipitated with antibodies to Sp1 (lane 4), Sp3 (lane 5), NF-1 (lane 6), TFIIB (lane 7), or in the absence of antibody (lane 3). PCR was performed with specific primers for the P2X1, H4 and Hsp70 promoter and for the GAPDH coding region as a negative control. A sample representative of the total input chromatin (input DNA lane 1) was included in the PCR analysis. Lane 2 shows the supernatant of the 'unbound' sample. PCR products were between 282 and 983 bp in length. PCR cycle numbers were 31 for the P2X1, H4 and Hsp70 promoter and 36 for the GAPDH coding region. Primer sequences are given in Table 3.
###end p 126
###begin p 127
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 37 39 37 39 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 0 52 0 52 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cross species conservation of the <italic>P2X</italic><sub>1 </sub>core promoter</bold>
###xml 57 59 57 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 492 495 492 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 495 497 495 497 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 555 557 555 557 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 714 716 714 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 863 865 863 865 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1136 1138 1136 1138 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 130 133 <span type="species:ncbi:9615">dog</span>
###xml 177 180 <span type="species:ncbi:10116">rat</span>
###xml 228 233 <span type="species:ncbi:10090">mouse</span>
###xml 486 491 <span type="species:ncbi:9606">human</span>
###xml 546 551 <span type="species:ncbi:9606">human</span>
###xml 629 632 <span type="species:ncbi:9615">dog</span>
###xml 634 639 <span type="species:ncbi:10090">mouse</span>
###xml 644 647 <span type="species:ncbi:10116">rat</span>
###xml 705 710 <span type="species:ncbi:9606">human</span>
###xml 854 859 <span type="species:ncbi:9606">human</span>
###xml 1127 1132 <span type="species:ncbi:9606">human</span>
Cross species conservation of the P2X1 core promoter. P2X1 upstream sequence from chimp (chromosome 19 position 4051445-4051944), dog (chromosome 9 position 40295005-40295504), rat (chromosome 10 position 59889637-59890136) and mouse (chromosome 11 position 72611373-72611872) was obtained by BLAST searching of genomic databases via the ENSEMBL genome browser . The 500 bp upstream of the ATG start codon of each gene was aligned using CLUSTAL. Alignment equivalent to -68/+149 of the human P2X1 core promoter is shown. Sequence identity to the human P2X1 sequence over this region was 99.1%, 83.4%, 76.8%, and 75.9% for chimp, dog, mouse and rat respectively. "." indicates nucleotides identical to the human P2X1 sequence. Dashes indicate positions where gaps have been inserted in order to maintain the alignment. The transcription start site of the human P2X1 gene determined in this study is indicated as +1. Potential transcription start sites predicted by PROSCAN [17] are indicated as arrows. In each species, potential NF-1, Sp1a and Sp1b binding sites (indicated by boxes) are present in equivalent positions to the human P2X1 core promoter.
###end p 127
###begin p 128
Oligonucleotides used for EMSA. Primer sequences are 5' to 3'. Bold lowercase bases represent mutations with respect to the wild type sequence. Underlined sequences represent consensus binding sites for respective transcription factor.
###end p 128
###begin p 129
###xml 97 100 97 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P2X</italic>
###xml 100 102 100 102 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
Binding site mutants. Positions of mutations in mutant constructs. Schematic illustration of the P2X1 core promoter mutation constructs. "." indicates positions same as wild type. "~" indicates where sequence has been omitted for clarity.
###end p 129
###begin p 130
Oligonucleotides used for ChIP analysis. Primer sequences are 5' to 3'. At the end of oligonucleotide names, f: indicates a sense primer, r: indicates an antisense primer.
###end p 130

